CRISPR-Cas-amplified urinary biomarkers for multiplexed and portable cancer diagnostics
Liangliang Hao(Massachusetts Institute of Technology), Sangeeta N. Bhatia(Broad Institute)
Cited by 145
Related Papers
Microfluidic organs-on-chips
|Nature Biotechnology|2014|3.2k
Future cancer research priorities in the USA: a Lancet Oncology Commission
|The Lancet Oncology|2017|209
Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA
|Nature Biomedical Engineering|2023|146
Ligand‐Clustered “Patchy” Nanoparticles for Modulated Cellular Uptake and In Vivo Tumor Targeting
|Angewandte Chemie International Edition|2010|140
The challenges posed by cancer heterogeneity
|Nature Biotechnology|2012|106